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The skin microbiota interacts with the host immune response to maintain the homeostasis. Changes in 
the skin microbiota are linked to the onset and the progression of several diseases, including tumors. 
We characterized the skin surface and dermal microbiota of 11 dogs affected by spontaneous mast 
cell tumor (MCT), using skin contralateral sites as intra-animal healthy controls. The microbial profile 
differed between healthy and tumor skin surfaces and dermis, demonstrating that the change in 
microbiota composition is related to the presence of MCT. The number of observed taxa between MCT 
and healthy skin surfaces was detected, showing a decrease in number and heterogeneity of taxa 
over the skin surface of MCT, at both inter- and intra-individual level. Preliminary data on bacterial 
population of MCT dermis, obtained only on three dogs, demonstrated an intra-individual reduction of 
taxa number when compared to the skin surface. Taxonomy reveals an increase of Firmicutes phylum 
and Corynebacteriaceae family in MCT skin surface when compared to the healthy contralateral. In 
conclusion, we demonstrate that microbial population of skin surface and dermis is related to mast cell 
tumor. Our study provides the basis for future investigations aiming to better define the interaction 
between mast cell tumors, microbiota and host immune response.
The epidermis, or skin surface, provides the external layer to the three parts of the skin, the inner layer being 
the dermis and hypodermis. The epidermis is regarded as a microenvironment containing a rich eukaryotic and 
prokaryotic population, currently defined as the  microbiota1,2, which plays a role as protective and immunologi-
cal  barrier3.
Culture-independent determination of the microbial profile of dog skin surface has been recently determined, 
showing that microbiota largely differs between body  sites4. The skin microbiota is modulated by extrinsic (e.g. 
diet, environment) and intrinsic (e.g. genetics)  factors5, and is not only limited to skin surface but also extends 
to the  dermis6. Remarkably, bacteria detected within the human healthy dermis and subcutaneous adipose tissue 
showed a different microbial population profile as compared to the skin  surface7. Four major phyla—namely 
Actinobacteria, Firmicutes, Proteobacteria, Bacteroidetes—and four major families—namely Corynebacteriaceae, 
Propionibacteriaceae, Staphylococcaceae, Micrococcaceae—dominate both  canine2 and human epidermal  surfaces1.
Given the limited number of studies, the definition of canine skin “healthy microbiota” is still debated. 
Changes in microbiota composition are associated with the development of skin disorders in both humans and 
 dogs8,9, as previously reported  dermatitis10 in dogs.
The defensive capability of skin is supported by healthy and balanced microbiota through the interaction 
with the residing immune cells in the  cutis9,11,12. Due to their localization within the skin, mast cells are in close 
contact with the bacterial  population13. The activities of mast cells may be amplified when changes in micro-
biota composition  occur14. The relationship between mast cells and skin surface  microbiota15 has been poorly 
investigated, so far.
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Canine Mast Cell Tumor (MCT) arises from an uncontrolled proliferation of neoplastic mast cells in cutane-
ous and subcutaneous tissues and is one of the most common skin neoplasms in dogs, accounting for up to 21% 
of all skin  tumours16. The alterations of the microbiota of epidermal surface and its relationship with tumors 
have been investigated in humans and in experimental  animals17,18. The onset of MCT and the presence of a 
high number of mast cells, the degranulation of which triggers a release of histamine, heparin and proteases, 
collectively defined as Darier’s  signs19, could lead to changes in microbiota at both skin surface and dermis level. 
This hypothesis is supported by a study performed on P815, a mouse mastocytoma tumor model, showing that 
butyrate, an intestinal microbial metabolite, was able to modulate mast  cells20.
To the best of our knowledge, no investigation has been carried out to characterize the skin surface micro-
biota of dogs affected by MCT. The presence of bacteria in the dermis of dogs remains unexplored as well. The 
present investigation aimed to profile the skin surface and dermis microbiota of owned-client dogs affected by 
spontaneous mast cell tumors in order to elucidate if and how the microbial community can change as associ-
ated with the neoplasm.
Results
Sequencing results. After sequencing, a total of 17 samples (8 skin swabs, 6 tumor dermal biopsies and 
3 healthy tissue biopsies) showed a low reads count that led to their exclusion from subsequent analyses. The 
sequencing data of the remaining 19 samples from 9 dogs, including 14 skin swabs and 5 tumor dermal biopsies, 
produced a total of 1,906,333 reads and 5,869 features were obtained with an average of 54,399 (a minimum of 
4,542 and a maximum of 459,808 sequences) after filtering. Detailed sequencing data for each sample are avail-
able in Supplementary Table S1 online.
Skin surface microbiota. Taxonomy results at phylum and family level are shown in Fig. 1a,b, respec-
tively. An abundance of 2% was arbitrarily selected as the cut-off for the analysis. All taxa found at phylum and 
family level are provided in Supplementary Table S2 online. At the phylum level, the most representative taxa 
on dog skin surface were Actinobacteria, Bacteroidetes, Firmicutes, Fusobacteria and Proteobacteria. Firmicutes 
showed an increase in their abundance in MCT as compared to healthy skin samples (mean of 30% ± 4.8% and 
21% ± 9.7% in tumor and healthy, respectively; p = 0.030). The most abundant families were Corynebacteriaceae, 
Staphylococcaceae, Moraxellaceae, Mycoplasmataceae. A statistically significant increase of Corynebacteriaceae 
was found on the tumor skin surface as compared to healthy contralateral (mean of 6.5% ± 3.4% and 2.4% ± 0.7% 
for tumor and healthy, respectively; p = 0.050).
The alpha diversity was investigated to study the species richness (number of OTU) and their relative abun-
dance (Shannon index), whereas the beta diversity was calculated to assess the microbiota structure using quali-
tative (unweighted UniFrac) and quantitative (weighted UniFrac) approaches without taking into account the 
phylogeny (Bray–Curtis).
The expected mean percentage of observed taxa was 63.06% (confidence interval 59–67%) and 36.94% (con-
fidence interval 33–40%) for healthy and tumor skin surface, respectively. Within alpha diversity analysis, the 
observed species decreased over the tumor skin surface (p < 0.001) at the Chi-square test (Supplementary Table S3 
online). In 3 out of 5 samples, a significant reduction (p = 0.02) of observed taxa on the tumor skin surface respec-
tively to the healthy skin contralateral was observed. Two animals showed a remarkably different pattern; dog 
D2 presented the same number of observed species in the MCT and the contralateral sample, whereas in dog D7 
the number of observed species increased in MCT. Considering all samples, the mean and standard deviation 
of observed taxa among groups were 599 ± 324 and 351 ± 324 for healthy and tumor samples, respectively. Tak-
ing into account the microorganisms’ abundance, the groups did not show any variation in the Shannon index.
Comparing the beta diversity of microbial structure in tumor and healthy skin surface, the dissimilarity was 
calculated by three distance matrices, namely unweighted UniFrac, weighted UniFrac and Bray–Curtis. Regarding 
the intra-group variation, a change in distances between healthy (mean of 0.37 ± 0.13) and tumor skin surface 
(mean of 0.26 ± 0.02) groups was observed in weighted UniFrac matrix (p = 0.02). Healthy skin samples present 
more divergent diversities than the more homogeneous diversities of MCT samples (Fig. 2).
Comparing the intra-animal distances, statistically significant changes in the microbiota structure were found 
for unweighted UniFrac (healthy vs tumor skin distance mean of 0.69 ± 0.08, p < 0.001), weighted UniFrac (healthy 
vs tumor skin distance mean of 0.29 ± 0.11, p = 0.004) and Bray–Curtis (healthy vs tumor skin distance mean of 
0.78 ± 0.079, p < 0.001) distance methods (Supplementary Table S4 online).
The multi-dimensional scaling (MDS) analysis based on all distances present between skin samples of 
unweighted and weighted UniFrac distances is reported in Fig. 3a,b, respectively. A shift of the healthy and 
tumor skin surfaces paired samples towards the same direction in the second dimension of the plot in both 
matrices, highlighting a clear separation between tumor and healthy skin surface groups by the y-axis, is visible. 
As previously described in alpha diversity, dog D7 presented an opposite behavior also in beta diversity. MDS 
analysis was also shown using Bray–Curtis distances (Supplementary Figure S1 online).
The contribution of the taxa with a relative abundance ≥ 2% that mostly drove the shift from healthy to the 
tumor skin surface is presented in Fig. 4.
Preliminary characterization of the microbiota composition of tumor dermis and compari-
son with its associated skin surface. After quality control step, the preliminary characterization of the 
microbiota composition of the tumor dermis was carried out on 5 tumor biopsies. An abundance of 2% was 
arbitrarily selected as the cut-off for the analysis. Results are presented in Fig. 1a,b for phylum and families, 
respectively. The most representative phyla of dermal microbiota were similar to those of skin surface. At fam-
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Figure 1.  Skin surface and dermis taxonomy profile of MCT affected dogs. Taxonomy of seven healthy skin 
surfaces and seven tumor skin surfaces and five dermis is shown at phylum (a) and family (b) level, respectively.
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Figure 2.  Box plots of unweighted, weighted UniFrac and Bray–Curtis distances between tumor skin and 
healthy skin surface groups. Weighted UniFrac matrix shows an intra-group variation in distances between 
healthy and tumor skin surface (p = 0.02).
Figure 3.  Multidimensional scaling plots of unweighted (a) and weighted (b) UniFrac distances comparing 
healthy (green circle) and tumor skin (red circle) surfaces. The arrows highlight the intra-animal shift from 
healthy and tumor skin surfaces.
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ily level, Corynebacteriaceae, Staphylococcaceae, Moraxellaceae, Peptostreptococcaceae, Porphyromonadaceae and 
Nocardiaceae were the most abundant.
Alpha and beta diversities between tumor dermis and the associated epidermal surface were also analyzed. 
A very preliminary statistical analysis was performed on alpha and beta diversity comparing the microbiota 
composition of the tumor dermis with overlying skin microbiota in 3 paired samples. Intra-animal chi-square 
test showed a difference in observed taxa between dermis and skin surface. The expected percentage of observed 
ASVs estimated by the test was 63.33% and 36.67% in skin surfaces and dermis, respectively (tumor skin swab 
CI: 58–67%; tumor dermis CI: 31–41%). A decrease in the number of ASVs detected in the dermis was found 
as compared to the corresponding skin surface (p < 0.001). The number of observed OTUs is presented in Sup-
plementary Table S3 online. No difference was detected between dermis and skin surface microbiota using a 
quantitative test or analyzing the microbiota structure through the Shannon index. Intra-animal beta diversity 
analysis showed differences between tumor dermis and skin surfaces in unweighted (dermis vs tumor skin 
distance mean of 0.66 ± 0.09, p = 0.006), weighted (dermis vs tumor skin distance mean of 0.35 ± 0.14, p = 0.047) 
UniFrac and Bray–Curtis (dermis vs tumor skin distance mean of 0.80 ± 0.05, p = 0.001) matrices (Supplemen-
tary Table S4 online). No variation was found comparing dermis and skin intra-groups (data not shown). The 
contribution of the main taxa which drove the shift between tumor skin surface and dermis is shown in Fig. 4 
Figure 4.  Balloon plots showing the contribution of the taxa (with a relative abundance ≥ 2%) which explain the 
shift from healthy to the tumor skin surface at phylum and family level.
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and it is represented through the MDS plot of unweighted, weighted and the Bray–Curtis matrices, shown in 
Supplementary Figure S1 online.
Core microbiota in skin surface and dermis of MCT affected dogs. The core microbiota, defined 
as the bacterial taxa shared by all the analyzed samples, was identified in the tumor skin surface, contralateral 
healthy skin surfaces and in tumor dermis (Fig. 5). The core microbiota of tumor skin surface is composed of 
12 ASVs, 6 of this shared with contralateral healthy skin surfaces and tumor dermis, belonged to 6 main fami-
lies, namely Corynebacteriaceae, Micrococcaceae, Propinibacteriaceae, Staphylococcaceae, Streptococaceae and 
Pseudomonadales. Ten ASVs are present only in the tumor, 3 only on the tumor skin surface (Moraxellaceae, 
Clostridiaceae, Pasteurellaceae—families) and 6 only in the tumor dermis (Nocardiaceae, Shewanellaceae, Entero-
bacteriaceae, Comamonadaceae, Corynebacteriaceae—families). One ASVs is shared by tumor skin and dermis 
belonged to Moraxallaceae family.
Discussion
In the present study, the microbial population over the skin surface and within the dermis of dogs affected by 
spontaneous mast cell tumor was investigated for the first time by determining the microbiota after amplification 
and sequencing of the V4 region of 16S  rRNA21. The significant changes detected in the microbiota community 
provided the evidence that it is possible to discriminate between healthy and mast cell tumor site, even if with 
the limited number of samples included in this study.
Our results revealed that the number of observed OTUs decreased on the tumor skin surface compared to 
the healthy contralateral, suggesting a lost in the heterogeneity of microbial community on the skin surface over 
the tumor area.
Core microbiota of the healthy contralateral skin surface included more bacterial types (27 ASVs) than those 
of tumor skin surface or dermis (12 and 16 ASVs, respectively), confirming that a decrease in microbial diversity 
characterizes the tumor site, as already observed during an unhealthy  status22,23.
We found that it is possible to discriminate the intra-patient tumor skin surface from healthy contralateral, 
as determined by beta diversity analysis using the weighted UniFrac matrix.
Several studies were carried out to investigate the relationship between microbiota and the development 
of skin disorders, including tumor and dermatitis. In the present study, an increase of Firmicutes phylum was 
observed, while investigation on human oral and pancreatic  cancer24 reported a reduction of this phylum, high-
lighting that different cancers exert different selective pressures on the microbial population. Our results reported 
also an increase of Corynebacteriaceae family on the tumor skin surface compared to the healthy contralateral. 
Studies on dermatitis described a decrease in microbiota  diversity10 with an increase of Corynebacteriaceae25, sug-
gesting that a compromised skin  barrier26 and local immune  response11 are associated with changes in microbiota 
composition. All MCT samples included in this study featured an increase of Corynebacteriaceae, except dog 7, 
which had an opposite profile. Given the background that this was the only patient with ulcerations, we speculate 
that the development of a huge inflammatory reaction over the skin may potentially hamper the analyses and 
probably explain the inconsistent results, as previously  described27.
Figure 5.  Venn diagram of ASVs, shared by tumor, healthy skin surface and tumor dermis which define core 
microbiota.
7Vol.:(0123456789)
Scientific RepoRtS |        (2020) 10:12634  | https://doi.org/10.1038/s41598-020-69572-0
www.nature.com/scientificreports/
Differences detected on the skin surface of MCT affected dogs suggest that tumor could interfere with the 
microbial population. The clonal proliferation of neoplastic mast  cells19,28 and the presence of other immune 
 cells29 infiltrating the tumor play a role in the host-microbiota  interaction30. No data are available about the 
relationship between mast cells and surface microbiota. Skin microbiome can influence mast cell migration, 
localization and maturation in the  skin31. A study on mouse skin microbiota supported its ability to recruit 
mast cells, promoting their maturation in dermis via stem cell factor  production32. Furthermore, the activation 
of mast cells can be boosted by molecules produced by bacteria, such as δ-toxin released by S.aureus during 
atopic  dermatitis33,34. The relationship between mast cells and microbiota is particularly interesting due to the 
microbiota capability to activate immune cells within the tumor microenvironment, and the potential exploiting 
of bacterial derived molecules to boost tumor immune  defense35.
In the second part of the study, we focused on the presence of bacteria in dermis and on the comparison of 
dermis with the skin surface microbiota. The sequencing data demonstrated that bacteria were detectable in 5 
out of 11 tumor dermal biopsies. On the contrary, the bacterial DNA was unquantifiable in the 3 healthy tissue 
biopsies, due to the low reads number. The limited number of case blocks any speculation about the possible 
relationship between dermis microbiota and the staging/grading of the MCT cases included in the study. In 
general, the presence of microbiota in the dermis has been poorly investigated so far, but having detected bacte-
rial DNA in dermal compartment is a relevant finding for future investigation. Bacterial DNA was found in the 
dermal  compartment6 and more recently human’s sebaceous and sweat glands were found to be inhabited by 
Propionibacterium spp and Corynebacterium spp,  respectively36.
The comparison of the microbial population of tumor dermis and of tumor skin surface revealed a decrease 
in the number of OTUs in tumor dermis as well as a difference in intra-patient beta-diversity. Both these findings 
are corroborated by previously results, which reported that the skin surface is characterized by a greater bacterial 
abundance and community richness than  biopsies7.
conclusions
The relationship between skin microbiota and MCT in dogs has yet to be fully elucidated. The next-generation 
sequencing approach allowed to demonstrate for the first time that the presence of MCT promotes an alteration 
of the epidermis microbiota structure and composition when compared to healthy skin; few differences were 
detected between tumor dermis and the associated epidermal surface microbiota, beside the decrease of ASV. 
Although the number of clinical case is limited, and the different stages and grades were not included in the 
statistical analysis, these preliminary findings pave the way to elucidate the relationship between mast cell tumor 
and composition of skin microbiota. Further studies on a larger number of patients are needed to support the 
reported results, which, if confirmed, have the potential to increase the knowledge of MCT pathophysiology 
and diagnostic.
Materials and methods
Ethics statement. The samples were collected at the Veterinary Teaching Hospital of the Università degli 
Studi di Milano from client-owned dogs that underwent veterinary consultation and surgery during the routine 
oncological management of canine mast cell tumor. All experimental procedures were reviewed and approved 
by the Ethics Committee of the University of Milano (approval number 118/19). Patients were recruited after 
written owner consent. All experiments were performed in accordance with the relevant guidelines and regula-
tions.
Studied population and sample collection. The experimental group was composed of 14 client-owned 
dogs, of which 11 were diagnosed with spontaneous MCT and three were healthy animals. All patients were 
companion dogs heterogeneous for the breed, age and gender. Detailed information about the enrolled animals 
is provided in Supplementary Table S5 online. Dogs with MCT were  staged37 in order to exclude  metastasis38 
and were admitted to MCT wide margins excision and surgical removal of the sentinel lymph node. Tumors 
were histologically  classified39 and grading was  assessed40,41. In addition, the neoplastic involvement of sentinel 
lymph-node was assessed as previously  described42.
From each MCT affected the dog, skin microbiota was collected using Sterile Dryswab (Medical wire) from 
the hairless area of the tumor and healthy contralateral site in the surgery room as previously  described4. The 
surgical field was then scrubbed with an antiseptic solution of 2% chlorhexidine acetate as standard surgical 
preparation. To determine the dermis microbiota content, 4 to 5-mm punch biopsies from the center of the 
MCT mass, corresponding to dermis, were collected after the tumor excision and preserved in RNAlater solu-
tion (Sigma). Biopsies of cutaneous tissue derived from the margin of the surgical incision were collected from 
3 healthy dogs that underwent elective sterilization, as healthy controls. Dermal biopsies from contralateral sites 
from MCT affected animals were not carried out for ethical reasons. Skin swabs and biopsies were then stored 
at − 80 °C until DNA extraction.
DNA extraction, library preparation and sequencing. The DNA was extracted from skin swabs and 
tissue biopsies using DNeasy PowerSoil Kit (Qiagen, catalogue number 12888-100) following the manufacture’s 
general procedures, with some differences. Briefly, the skin swabs were cut directly into the PowerBead Tubes 
with Solution C1, vortexed and centrifuged at 10,000×g for 30 s; the supernatant was used for extraction. Twenty 
mg of the dermal biopsy were cut, treated with 20 µl of Proteinase K (Qiagen) and 60 µl of Buffer C1, incubated 
at 65 °C for 30 min and then transferred in the PowerBead Tubes to continue the procedure. Extraction blanks, 
processed like the other samples, were included for each extraction batch, as a control for contaminants. The 
DNA obtained from swabs and tissues were eluted in 30 µl and 60 µl of DNase-RNase free water, respectively, 
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and stored at − 20 °C until use. DNA quantity and purity were checked using NanoDrop 1,000 Spectrophotom-
eter (Thermo Scientific) at wavelengths 230, 260 and 280 nm.
V4 region of 16S rRNA gene was amplified using the following primer pair, the Forward primer—(5′-CCA 
TCT CAT CCC TGC GTG TCT CCG ACTCAG NNNNNNNNNNNNNNNNNGAT GTG YCA GCMGCC GCG 
GTAA-3′) composed of the adapter linker, the key, the sample-specific barcode and the F515 forward primer 
and the Reverse primer (5′-CTC TCT ATG GGC AGT CGG TGA TGG ACTACNVGGG TWT CTAAT-3′) composed 
of the adapter linker and the R806 reverse primer. The Thermo Scientific Phusion Hot Start II High-Fidelity 
DNA polymerase kit (Thermo Fisher Scientific) was used to perform the PCR in 25 μl of the final volume. The 
mix contained RNAse and DNAse free water, 5 × Phusion Buffer HF (5 μl), dNTPs 2 mM (2.5 μl), Primer Fw 
10 µM (1.25 μl), primer Rv 10 µM (1.25 μl) and Phusion High Fidelity Taq polymerase 2 U/μl (0.25 μl), and 5 ng 
of input DNA for dermal biopsy samples and 2.5 μl for the skin surface samples with an unquantifiable concen-
tration. The thermal profile consisted of an initial denaturation of 30 s at 98 °C, followed by 27 cycles of 15 s at 
98 °C, 15 s at 55 °C, 20 s at 72 °C and a final extension of 7 min at 72 °C. Quality and quantity of amplification 
were assessed in all samples, including extraction blanks and non-template controls (NTC), through Agilent 
Bioanalyzer 2,100 and Qubit fluorometer. The nucleic acid concentration of 12 (7 swabs and 5 biopsies) out of 
33 samples was lower than 1 ng/μl after 27 cycles of PCR. Thus, an additional PCR was applied to these samples 
using the same condition increasing the number of cycles to 32. Each PCR reaction included an NTC to confirm 
the absence of contaminants in the reagents. The DNA sequencing was performed using an Ion Torrent Personal 
Genome Machine (PGM) with the Ion 318 Chip v2 (Thermo Fisher Scientific), following the manufacturer’s 
instructions. A mock community (ZymoBIOMICS Microbial Community DNA Standard, Zymo Research), as 
a positive control, was also sequenced to assess the quality of the run. In addition, 4 extraction blanks (2 from 
skin swabs DNA purification and 2 from tissue biopsy DNA purification) and 2 not template controls from the 
two PCR amplification reactions were sequenced to exclude the presence of contaminants in the reagents. Taxa 
considered as contaminants were excluded from all the samples analyzed (Supplementary methods).
Quality control and sequence demultiplexing. Raw sequences were submitted to the National 
Center for Biotechnology Information under Bioproject accession number SUB6027391—Bioproject number: 
PRJNA555200. Raw data were imported into Quantitative Insight Into Microbial Ecology 2 software (QIIME 
2; https ://qiime 2.org)43 for the analysis. Raw sequencing reads were demultiplexed to remove the Rv primer 
sequence and to associate each barcode to the correspondent sample.  DADA244 was used to denoise, dereplicate 
single-end sequences and remove chimaeras. Reads with a length of 253 bp were taken into account, considering 
the quality plot result and the V4 length mean of 250 bases. After that, the Amplicon Sequence Variants (ASVs), 
units of observation composed of unique sequences, were used to classify them and assign taxonomy using 
 SILVA45 at 99% of Operational Taxonomic Units (OTUs) identity and trimmed to V4 region, as the reference 
database. The complete workflow is provided in Supplementary Methods online.
Statistical analysis. Statistical analysis was performed using XLStat software for Windows (Addinsoft, 
New York, USA) on taxonomy and alpha and beta diversities. Data distribution was assessed using the Shapiro–
Wilk test. From taxonomy results, the relative abundance of taxa present was determined in all samples. Alpha 
diversity describes the differences within samples or groups and indicates how many taxa are present by using 
a qualitative (observed species or observed ASVs) and a quantitative (Shannon index) approach. Beta diversity 
defines the differences between groups and takes into account how many taxa are shared between samples, gen-
erating distance matrices. We analyzed the beta diversity through unweighted and weighted UniFrac methods as 
a phylogenetic qualitative and quantitative approach, respectively and Bray Curtis analysis that does not consider 
the microbial community phylogeny. For both alpha and beta diversity, a sequence depth of 4,500 was applied.
The statistical analysis was performed on paired samples to assess the microbiota variation within the same 
individual. To characterize the core microbiota, we analyzed the shared ASVs between groups, considering the 
cutoff of 80% for the presence of the features within the groups. The difference between observed and expected 
features for healthy and tumor tissues was calculated by means of Chi-square test. T-test, Wilcoxon-signed- and 
Mann–Whitney-tests were applied based on the distribution of each dataset. Statistical significance was accepted 
at p-value ≤ 0.05.
For graphical representations, we plotted the shared ASVs using an online Venn tool (https ://bioin forma tics.
psb.ugent .be/webto ols/Venn/).
Multi-dimensional scaling (MDS) analysis was generated by means of XLStat software considering the dis-
tance matrix calculated on unweighted and weighted UniFrac and Bray–Curtis by QIIME2. The Kruskal’s stress 
(from 0 to 1) was taken into account to evaluate the goodness-of-fit of the test, with values closer to zero corre-
sponding to a better and more reliable data representation. Box- and bar-plots were produced using R software 
(https ://www.R-proje ct.org) by the R package ggplot2 (https ://cran.r-proje ct.org/web/packa ges/ggplo t2/, version 
3.2.0) as shown in the Supplementary Methods online.
In addition to the previous multi-dimensional scaling, we produced a second MDS plot using the R cmdscale 
function on the Manhattan distances calculated on the relative abundance matrices for both samples and ASVs 
(both part of the R built-in stats package, R version 3.5.2). This step was carried out for both phyla and families 
separately, and for the skin and the dermal biopsy separately, for a total of four different analyses. Eigenvalues 
for the ASVs have been plotted as bar charts to identify the leading eigenvalues. Finally, a principal component 
analysis (PCA) using the PCA function in FactoMineR  package46 (https ://cran.r-proje ct.org/web/packa ges/Facto 
MineR /, version 1.42), allowing for the detection of the percentage of contribution of every ASVs to the different 
components, was carried out. For this study, only the contribution to the first component was considered. The 
detailed bioinformatics workflow is available in Supplementary Methods online.
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